当センターは世界最大級のリウマチセンターであり、最新の研究活動とその結果得られる最新情報の発信は我々に与えられた重要な使命の一つと考えております。これまでにIORRAコホートや病棟で蓄積された数多くの症例を背景とした臨床研究、多彩なフィールドでの基礎研究などで多くの業績をあげており、また世界最大級の患者数を誇る施設であるため、貴重な症例の報告も積極的におこなっています。
関節リウマチ
1. Harigai M, Tanaka E, Inoue E, Tamura N, Misaki K, Azuma T, Hirata S, Hirano F, Taniguchi Y, Mitsuhashi M, Kondo M, Oribe M, Aoki K, Kadode M, Tsuritani K, Yamanaka H. Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: post-hoc subgroup analyses of the Japanese real-world observational ORIGAMI study Mod Rheumatol. 2023 Aug 25:road082. doi: 10.1093/mr/road082. Online ahead of print. PMID37624029
2. Nanke Y. The Pathogenesis of Rheumatoid Arthritis Breakthroughs in Molecular Mechanisms 1 and 2 Int J Mol Sci. 2023 Jul 4;24(13):11060. doi: 10.3390/ijms241311060. PMID37446237
3. Sakai R, Tanaka E, Inoue E, Sato M, Tanaka M, Ikari K, Yamanaka H, Harigai M. Subjective symptoms contributing to the quality of life of rheumatoid arthritis patients with clinical remission from the IORRA database Mod Rheumatol. 2023 Apr 13;33(3):496-502. doi: 10.1093/mr/roac053. PMID35652691
4. James EA, Holers VM, Iyer R, Prideaux EB, Rao NL, Rims C, Muir VS, Posso SE, Bloom MS, Zia A, Elliott SE, Adamska JZ, Ai R, Brewer RC, Seifert JA, Moss L, Barzideh S, Demoruelle MK, Striebich CC, Okamoto Y, Sainbayar E, Crook AA, Peterson RA, Vanderlinden LA, Wang W, Boyle DL, Robinson WH, Buckner JH, Firestein GS, Deane KD. Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis Nat Commun. 2023 Nov 22;14(1):7637. doi: 10.1038/s41467-023-43091-8. PMID37993439
5. Azuma T, Misaki K, Kusaoi M, Suzuki Y, Higa S, Kumon Y, Yoshitama T, Naniwa T, Yamada S, Okano T, Takeuchi K, Ikeda K, Higami K, Inoo M, Sawada T, Kang C, Hayashi M, Nagaya Y, Hagiwara T, Shono E, Himeno S, Tanaka E, Inoue E, Yoshizawa Y, Kadode M, Yamanaka H, Harigai M. Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI study Mod Rheumatol. 2023 Mar 2;33(2):271-278. doi: 10.1093/mr/roac032. PMID35389481
6. Kawahito Y, Morinobu A, Kaneko Y, Kohno M, Hirata S, Kishimoto M, Seto Y, Sugihara T, Tanaka E, Ito H, Kojima T, Matsushita I, Nishida K, Mori M, Murashima A, Yamanaka H, Nakayama T, Kojima M, Harigai M. Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication Mod Rheumatol. 2023 Jan 3;33(1):21-35. doi: 10.1093/mr/roac017. PMID35297492
7. Tominaga A, Ikari K, Yano K, Tanaka E, Inoue E, Harigai M, Okazaki K. Surgical intervention for patients with rheumatoid arthritis is declining except for foot and ankle surgery: A single-centre, 20-year observational cohort study Mod Rheumatol. 2023 Apr 13;33(3):509-516. doi: 10.1093/mr/roac042. PMID35536604
8. Sugimoto N, Tanaka E, Inoue E, Abe M, Sugano E, Sugitani N, Saka K, Ochiai M, Higuchi Y, Yamaguchi R, Ikari K, Nakajima A, Yamanaka H, Harigai M. Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort Mod Rheumatol. 2023 Jul 4;33(4):715-722. doi: 10.1093/mr/roac085. PMID35920098
9. Sakai R, Tanaka E, Inoue E, Sato M, Tanaka M, Ikari K, Yamanaka H, Harigai M. Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA database Mod Rheumatol. 2023 Aug 25;33(5):899-905. doi: 10.1093/mr/roac105. PMID36094815
10. Higuchi T, Tanaka E, Inoue E, Abe M, Saka K, Sugano E, Sugitani N, Higuchi Y, Ochiai M, Yamaguchi R, Ikari K, Yamanaka H, Harigai M. Evaluation of RABBIT risk score in Japanese patients with rheumatoid arthritis starting first bDMARDs: a validation study using the IORRA cohort data Mod Rheumatol. 2023 Jul 6:road066. doi: 10.1093/mr/road066. Online ahead of print. PMID37409749
11. Ito H, Nishida K, Kojima T, Matsushita I, Kojima M, Hirata S, Kaneko Y, Kishimoto M, Kohno M, Mori M, Morinobu A, Murashima A, Seto Y, Sugihara T, Tanaka E, Nakayama T, Yamanaka H, Kawahito Y, Harigai M. Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication Mod Rheumatol. 2023 Jan 3;33(1):36-45. doi: 10.1093/mr/roac019. PMID35294030
リウマチ整形
1. Mochizuki T, Yano K, Ikari K, Okazaki K. Radiological evaluation of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept or JAK inhibitors for 1 year Respir Investig. 2023 May;61(3):359-363. doi: 10.1016/j.resinv.2023.02.007. Epub 2023 Apr 7. PMID37031622
2. Mochizuki T, Yano K, Ikari K, Hiroshima R, Okazaki K. Comparison of romosozumab versus denosumab treatment on bone mineral density after 1 year in rheumatoid arthritis patients with severe osteoporosis: A randomized clinical pilot study Mod Rheumatol. 2023 Apr 13;33(3):490-495. doi: 10.1093/mr/roac059. PMID35689558
3. Mochizuki T, Yano K, Ikari K, Okazaki K. Cut-off values for achieving osteoporosis treatment goals in women with rheumatoid arthritis receiving denosumab Mod Rheumatol. 2023 Nov 1;33(6):1204-1206. doi: 10.1093/mr/roac145. PMID36484528
4. Mochizuki T, Yano K, Ikari K, Okazaki K. Effectiveness of locomotion training in patients with rheumatoid arthritis: a prospective clinical trial J Phys Ther Sci. 2023 Dec;35(12):810-816. doi: 10.1589/jpts.35.810. Epub 2023 Dec 1. PMID38075516
5. Mochizuki T, Yano K, Ikari K, Okazaki K. Factors Associated with Five-year Deterioration of the Health Assessment Questionnaire-Disability Index in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study Intern Med. 2023 Jun 15;62(12):1733-1737. doi: 10.2169/internalmedicine.0651-22. Epub 2022 Nov 2. PMID36328576
6. Mochizuki T, Hoshi K, Yano K, Koyama J, Kukidome H, Ikari K, Okazaki K. Smoking, Serum Albumin and 25-hydroxy Vitamin D Levels, and Bone Mineral Density Are Associated with Tooth Loss in Patients with Rheumatoid Arthritis Intern Med. 2023 Oct 1;62(19):2821-2825. doi: 10.2169/internalmedicine.1219-22. Epub 2023 Feb 22. PMID36823087
7. Tobimatsu H, Ikari K, Yano K, Okazaki K. Radiographic factors associated with painful callosities after forefoot surgery in patients with rheumatoid arthritis Mod Rheumatol. 2023 Jan 3;33(1):104-110. doi: 10.1093/mr/roab131. PMID34939107
8. Yano K, Ikari K, Okazaki K. Stress fractures in the forefoot after arthrodesis of the hindfoot in a patient with rheumatoid arthritis: A case report Mod Rheumatol Case Rep. 2023 Jan 3;7(1):19-23. doi: 10.1093/mrcr/rxac039. PMID35460244
9. Mochizuki T, Yano K, Ikari K, Okazaki K. Combination treatment with Janus kinase inhibitor and nintedanib for rheumatoid arthritis with progressive interstitial lung disease: A case report Mod Rheumatol Case Rep. 2023 Jun 19;7(2):350-353. doi: 10.1093/mrcr/rxad021. PMID37061836
10. Mochizuki T, Yano K, Ikari K, Okazaki K. Comparison of different parameters between daily and twice-weekly teriparatide in postmenopausal women with severe osteoporosis J Bone Miner Metab. 2023 Mar;41(2):220-226. doi: 10.1007/s00774-022-01398-4. Epub 2023 Jan 10. PMID36625920
11. Yano K, Ikari K, Okazaki K. Ten-Year Follow-Up of a Customized Total Talar Prosthesis for Revision Total Ankle Arthroplasty: A Case Report JBJS Case Connect. 2023 Aug 17;13(3). doi: 10.2106/JBJS.CC.23.00115. eCollection 2023 Jul 1. PMID37590560
12. Mochizuki T, Hori T, Yano K, Ikari K, Okazaki K. Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers Clin Exp Vaccine Res. 2023 Apr;12(2):116-120. doi: 10.7774/cevr.2023.12.2.116. Epub 2023 Apr 30. PMID37214144
SLE
1. Yamashita S, Katsumata Y, Konda N, Kandane-Rathnayake R, Morand EF, Harigai M. Comparisons between US norm-based two-component and Japanese norm-based three-component SF-36 summary scores in systemic lupus erythematosus patients Mod Rheumatol. 2023 Apr 13;33(3):517-524. doi: 10.1093/mr/roac061. PMID35689562
2. Connelly K, Kandane-Rathnayake R, Hoi A, Louthrenoo W, Hamijoyo L, Luo SF, Wu YJ, Cho J, Lateef A, Lau CS, Chen YH, Navarra S, Zamora L, Li Z, An Y, Sockalingam S, Hao Y, Zhang Z, Chan M, Katsumata Y, Harigai M, Oon S, Bae SC, O'Neill S, Gibson KA, Basnayake B, Kikuchi J, Takeuchi T, Ng KPL, Tugnet N, Kumar S, Goldblatt F, Law A, Tee M, Tee C, Tanaka Y, Ohkubo N, Tan JY, Karyekar CS, Nikpour M, Golder V, Morand EF. Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study Arthritis Rheumatol. 2023 Mar;75(3):401-410. doi: 10.1002/art.42350. Epub 2022 Dec 16. PMID36122172
3. Motoyama R, Higuchi T, Hirahara S, Konda N, Yamada R, Watanabe K, Fujisaki M, Yamaguchi R, Katsumata Y, Kawaguchi Y, Harigai M. A case of systemic lupus erythematosus having concurrent Evans syndrome and acquired thrombotic thrombocytopenic purpura Mod Rheumatol Case Rep. 2023 Jun 19;7(2):383-387. doi: 10.1093/mrcr/rxad011. PMID36779528
4. Cho J, Shen L, Huq M, Kandane-Rathnayake R, Golder V, Louthrenoo W, Chen YH, Hamijoyo L, Luo SF, Wu YJ, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Oon S, O'Neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Navarra SV, Lau CS, Hoi A, Morand EF, Nikpour M, Lateef A; Asia-Pacific Lupus Collaboration. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study Lancet Rheumatol. 2023 Oct;5(10):e584-e593. doi: 10.1016/S2665-9913(23)00209-6. Epub 2023 Sep 12. PMID38251484
全身性強皮症
1. Kawaguchi Y, Kuwana M. Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis Curr Opin Rheumatol. 2023 Nov 1;35(6):309-316. doi: 10.1097/BOR.0000000000000959. Epub 2023 Jul 24. PMID37490353
2. Nishizawa Y, Katsura H, Sasaki Y, Kudo R, Kizuki A, Horimoto A, Ishikawa M, Takagi K, Kikuchi K, Sakura H, Nitta K, Hoshino J, Ogawa T. Secondary spontaneous pneumothorax in a patient with resistant Mycobacterium abscessus infection and systemic sclerosis-associated interstitial lung disease: A case report Respir Med Case Rep. 2023 Nov 5;46:101941. doi: 10.1016/j.rmcr.2023.101941. eCollection 2023. PMID38025248
3. Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Hirose H, Sawada T, Shibata N, Harigai M, Kawaguchi Y. Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model Sci Rep. 2023 Nov 8;13(1):19378. doi: 10.1038/s41598-023-46737-1. PMID37938601
皮膚筋炎/多発筋炎
1. Takahashi Y, Takamiya M, Ichimura Y, Okiyama N, Nishino I, Morimoto N. [Two cases of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with severe diffuse subcutaneous edema and dysphagia] Rinsho Shinkeigaku. 2023 Nov 23;63(11):737-742. doi: 10.5692/clinicalneurol.cn-001863. Epub 2023 Oct 25. PMID37880118
血管炎
1. Fujisaki M, Higuchi T, Konda N, Hirahara S, Watanabe K, Yamada R, Motoyama R, Yamaguchi R, Katsumata Y, Kawaguchi Y, Harigai M. Development of microscopic polyangiitis following idiopathic pleuroparenchymal l fibroelastosis: A case report Mod Rheumatol Case Rep. 2023 Dec 29;8(1):141-144. doi: 10.1093/mrcr/rxad035. PMID37307430
2. Harigai M, Miyamae T, Hashimoto H, Umetsu K, Yamashita K, Nakaoka Y. A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan Mod Rheumatol. 2023 Jul 31:road074. doi: 10.1093/mr/road074. Online ahead of print. PMID37522620
3. Nagasaka K, Amano K, Dobashi H, Nagafuchi H, Sada KE, Komagata Y, Yamamura M, Kato M, Endo T, Nakaya I, Takeuchi T, Murakawa Y, Sugihara T, Saito M, Hayashi T, Furuta S, Tamura N, Karasawa K, Banno S, Endo S, Majima M, Kaname S, Arimura Y, Harigai M. Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Effectiveness and safety in the first 6 months Mod Rheumatol. 2023 Nov 1;33(6):1117-1124. doi: 10.1093/mr/roac150. PMID36478050
4. Harigai M, Miyamae T, Hashimoto H, Yoshida A, Yamashita K, Nakaoka Y. A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge study Mod Rheumatol. 2023 Aug 25;33(5):998-1006. doi: 10.1093/mr/roac099. PMID36057089
5. Sugihara T, Uchida HA, Yoshifuji H, Maejima Y, Naniwa T, Katsumata Y, Okazaki T, Ishizaki J, Murakawa Y, Ogawa N, Dobashi H, Horita T, Tanaka Y, Furuta S, Takeuchi T, Komagata Y, Nakaoka Y, Harigai M. Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis Mod Rheumatol. 2023 Nov 1;33(6):1145-1153. doi: 10.1093/mr/roac122. PMID36218378
6. Kawasaki A, Sada KE, Kusumawati PA, Hirano F, Kobayashi S, Nagasaka K, Sugihara T, Ono N, Fujimoto T, Kusaoi M, Tamura N, Kusanagi Y, Itoh K, Sumida T, Yamagata K, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N. Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population Front Immunol. 2023 Mar 8;14:1119064. doi: 10.3389/fimmu.2023.1119064. eCollection 2023. PMID36969218
7. Miyawaki Y, Fujii T, Anan K, Kodera M, Kikuchi M, Sada KE, Nagasaka K, Bando M, Sugiyama H, Kaname S, Harigai M, Tamura N. Concordance between practice and published evidence in the management of ANCA-associated vasculitis in Japan: A cross-sectional web-questionnaire survey Mod Rheumatol. 2023 Aug 25;33(5):990-997. doi: 10.1093/mr/roac118. PMID36181464
8. Arimura Y, Sobue G, Hattori N, Takashima H, Harigai M, Nagata K, Makino H. Intravenous immunoglobulin for chronic residual peripheral neuropathy in microscopic polyangiitis: A multicentre randomised double-blind trial Mod Rheumatol. 2023 Nov 1;33(6):1125-1136. doi: 10.1093/mr/roac137. PMID36346309
9. Sada KE, Kaname S, Higuchi T, Furuta S, Nagasaka K, Nanki T, Tsuboi N, Amano K, Dobashi H, Hiromura K, Bando M, Wada T, Arimura Y, Makino H, Harigai M. Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody-associated vasculitis Mod Rheumatol. 2023 Dec 22;34(1):144-150. doi: 10.1093/mr/road017. PMID36715080
10. Nakaya I, Sada KE, Harigai M, Soma J, Amano K, Dobashi H, Atsumi T, Yuzawa Y, Fujimoto S, Sugihara T, Takasaki Y, Arimura Y, Makino H. Chemoprophylaxis against Pneumocystis jirovecii pneumonia in Japanese patients with ANCA-associated vasculitis: An observational study Mod Rheumatol. 2023 Nov 1;33(6):1137-1144. doi: 10.1093/mr/roac124. PMID36197746
11. Konda N, Sakai R, Saeki K, Matsubara Y, Nakamura Y, Miyamae T, Nakaoka Y, Harigai M. Nationwide clinical and epidemiological study of large-vessel vasculitis in Japan in 2017 Mod Rheumatol. 2023 Dec 22;34(1):167-174. doi: 10.1093/mr/road019. PMID36737863
12. Kurokawa M, Higuchi T, Hirahara S, Watanabe K, Yamada R, Nakamura S, Takada H, Majima M, Motoyama R, Hanaoka M, Katsumata Y, Harigai M. A case of Takayasu arteritis complicated with acute pericarditis at initial presentation Mod Rheumatol Case Rep. 2023 Jan 3;7(1):154-159. doi: 10.1093/mrcr/rxac067. PMID35993505
13. Watanabe R, Oshima M, Nishioka N, Sada KE, Nagasaka K, Akiyama M, Ando T, Higuchi T, Inoue Y, Kida T, Mutoh T, Nakabayashi A, Onishi A, Sakai R, Waki D, Yamada Y, Yajima N, Tamura N, Kaname S, Harigai M. Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis Mod Rheumatol. 2023 Aug 25;33(5):982-989. doi: 10.1093/mr/roac114. PMID36112482
14. Harigai M, Kaname S, Tamura N, Dobashi H, Kubono S, Yoshida T. Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study Mod Rheumatol. 2023 Mar 2;33(2):338-345. doi: 10.1093/mr/roac037. PMID35482532
15. Ishizu A, Kawakami T, Kanno H, Takahashi K, Miyazaki T, Ikeda E, Oharaseki T, Ogawa Y, Onimaru M, Kurata M, Nakazawa D, Muso E, Harigai M. Expert perspectives on pathological findings in vasculitis Mod Rheumatol. 2023 Jan 3;33(1):1-11. doi: 10.1093/mr/roac043. PMID35535676
小児リウマチ科
1. Kishi T, Nakano N, Narazaki H, Yashiro M, Hashimoto K, Shinoki T, Sato T, Kinjo N, Imanaka H, Bando Y, Inamo Y, Yamazaki K, Okamoto N. Survey of diversity awareness and environment among members of the Pediatric Rheumatology Association of Japan Pediatr Int. 2023 Jan-Dec;65(1):e15654. doi: 10.1111/ped.15654. PMID37837236
2. Narazaki H, Akioka S, Akutsu Y, Araki M, Fujieda M, Fukuhara D, Hara R, Hashimoto K, Hattori S, Hayashibe R, Imagawa T, Inoue Y, Ishida H, Ito S, Itoh Y, Kawabe T, Kitoh T, Kobayashi I, Matsubayashi T, Miyamae T, Mizuta M, Mori M, Murase A, Nakagishi Y, Nagatani K, Nakano N, Nishimura T, Nozawa T, Okamoto N, Okura Y, Sawada H, Sawanobori E, Sugita Y, Tanabe Y, Tomiita M, Yamaguchi KI, Yasuoka R, Yokoyama K. Epidemiology conduction of paediatric rheumatic diseases based on the registry database of the Pediatric Rheumatology Association of Japan Mod Rheumatol. 2023 Aug 25;33(5):1021-1029. doi: 10.1093/mr/roac112. PMID36112493
3. Wakiguchi H, Kaneko U, Sato S, Imagawa T, Narazaki H, Miyamae T. Clinical Features of COVID-19 in Pediatric Rheumatic Diseases: 2020-2022 Survey of the Pediatric Rheumatology Association of Japan Viruses. 2023 May 20;15(5):1205. doi: 10.3390/v15051205. PMID37243292
4. Miyamae T, Inoue E, Tanaka E, Kawabe T, Ikari K, Harigai M. Association of disease activity using SDAI and DAS28, but not JADAS-27, with subsequent changes in physical function in adult patients with juvenile idiopathic arthritis Mod Rheumatol. 2023 Apr 13;33(3):588-593. doi: 10.1093/mr/roac063. PMID35713223
その他
1. Fusama M, Nakahara H, Gregg M, Kuroe Y, Urata Y, Kawahata K, Kawahito Y, Kojima M, Sugihara T, Hashimoto M, Miyamae T, Murashima A, Mori M, Yajima N, Matsui T. Challenges faced by nurses engaged in rheumatology care in Japan Mod Rheumatol. 2023 Aug 4:road079. doi: 10.1093/mr/road079. Online ahead of print. PMID37540545
2. Honda S, Yano K, Tanaka E, Ikari K, Harigai M. Development of a scoring model for the Sharp/van der Heijde score using convolutional neural networks and its clinical application Rheumatology (Oxford). 2023 Jun 1;62(6):2272-2283. doi: 10.1093/rheumatology/keac586. PMID36218391
3. Yamazaki S, Izawa K, Matsushita M, Moriichi A, Kishida D, Yoshifuji H, Yamaji K, Nishikomori R, Mori M, Miyamae T. Promoting awareness of terminology related to unmet medical needs in context of rheumatic diseases in Japan: a systematic review for evaluating unmet medical needs Rheumatol Int. 2023 Nov;43(11):2021-2030. doi: 10.1007/s00296-023-05425-z. Epub 2023 Aug 19. PMID37597057
4. Bieber T, Feist E, Irvine AD, Harigai M, Haladyj E, Ball S, Deberdt W, Issa M, Grond S, Taylor PC. Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19 Adv Ther. 2023 Sep;40(9):4114-4115. doi: 10.1007/s12325-023-02526-w. Epub 2023 Jun 22. PMID37347406